1. Home
  2. IMMX vs GDC Comparison

IMMX vs GDC Comparison

Compare IMMX & GDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMX
  • GDC
  • Stock Information
  • Founded
  • IMMX 2014
  • GDC 2015
  • Country
  • IMMX United States
  • GDC United States
  • Employees
  • IMMX N/A
  • GDC N/A
  • Industry
  • IMMX Medicinal Chemicals and Botanical Products
  • GDC Steel/Iron Ore
  • Sector
  • IMMX Health Care
  • GDC Industrials
  • Exchange
  • IMMX Nasdaq
  • GDC Nasdaq
  • Market Cap
  • IMMX 65.5M
  • GDC 65.3M
  • IPO Year
  • IMMX 2021
  • GDC N/A
  • Fundamental
  • Price
  • IMMX $2.10
  • GDC $8.07
  • Analyst Decision
  • IMMX Strong Buy
  • GDC
  • Analyst Count
  • IMMX 1
  • GDC 0
  • Target Price
  • IMMX $8.00
  • GDC N/A
  • AVG Volume (30 Days)
  • IMMX 181.7K
  • GDC 114.3K
  • Earning Date
  • IMMX 11-11-2025
  • GDC 08-12-2025
  • Dividend Yield
  • IMMX N/A
  • GDC N/A
  • EPS Growth
  • IMMX N/A
  • GDC N/A
  • EPS
  • IMMX N/A
  • GDC N/A
  • Revenue
  • IMMX N/A
  • GDC N/A
  • Revenue This Year
  • IMMX N/A
  • GDC N/A
  • Revenue Next Year
  • IMMX N/A
  • GDC N/A
  • P/E Ratio
  • IMMX N/A
  • GDC N/A
  • Revenue Growth
  • IMMX N/A
  • GDC N/A
  • 52 Week Low
  • IMMX $1.26
  • GDC $1.03
  • 52 Week High
  • IMMX $3.20
  • GDC $8.22
  • Technical
  • Relative Strength Index (RSI)
  • IMMX 42.26
  • GDC 88.88
  • Support Level
  • IMMX $2.09
  • GDC $3.78
  • Resistance Level
  • IMMX $2.34
  • GDC $4.30
  • Average True Range (ATR)
  • IMMX 0.16
  • GDC 0.53
  • MACD
  • IMMX 0.01
  • GDC 0.39
  • Stochastic Oscillator
  • IMMX 35.90
  • GDC 96.46

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

About GDC GD Culture Group Limited

GD Culture Group Ltd focuses its business on two segments mainly through the Company and two subsidiaries. 1) AI-driven digital human creation and customization; 2) Live streaming and e-commerce. The company has relentlessly been focusing on serving its customers and creating value for them through the continual innovation and optimization of its products and services. For the AI-driven digital human creation and customization sector, the Company uses AI algorithms and software to generate realistic 3D or 2D digital human models. AI algorithms and machine learning models are used to simulate human characteristics, such as facial expressions, body movements, and even speech patterns.

Share on Social Networks: